A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessment
This paper presents a 10-step read-across (RAX) framework for use in cases where a threshold of toxicological concern (TTC) approach to cosmetics safety assessment is not possible. RAX builds on established approaches that have existed for more than two decades using chemical properties and in silic...
Gespeichert in:
Veröffentlicht in: | Regulatory toxicology and pharmacology 2022-03, Vol.129, p.105094-105094, Article 105094 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This paper presents a 10-step read-across (RAX) framework for use in cases where a threshold of toxicological concern (TTC) approach to cosmetics safety assessment is not possible. RAX builds on established approaches that have existed for more than two decades using chemical properties and in silico toxicology predictions, by further substantiating hypotheses on toxicological similarity of substances, and integrating new approach methodologies (NAM) in the biological and kinetic domains. NAM include new types of data on biological observations from, for example, in vitro assays, toxicogenomics, metabolomics, receptor binding screens and uses physiologically-based kinetic (PBK) modelling to inform about systemic exposure. NAM data can help to substantiate a mode/mechanism of action (MoA), and if similar chemicals can be shown to work by a similar MoA, a next generation risk assessment (NGRA) may be performed with acceptable confidence for a data-poor target substance with no or inadequate safety data, based on RAX approaches using data-rich analogue(s), and taking account of potency or kinetic/dynamic differences.
•A 10-step framework for applying read-across (RAX) and novel approach methods (NAM) in cosmetics safety assessment.•Confidence in using RAX and NAM in cosmetics safety assessment by defining mode(s) of action in biological effect pathways.•Incorporating physiologically-based biokinetic (PBK) modelling to refine cosmetics ingredient exposure assessments.•Using NAMs for both toxicokinetics and toxicodynamics in tiered and integrated assessment. |
---|---|
ISSN: | 0273-2300 1096-0295 |
DOI: | 10.1016/j.yrtph.2021.105094 |